Gossamer Bio Inc (GOSS) earnings · rev $48.5M
These earnings events as JSON? API free 100/dayGossamer Bio Inc (GOSS) is a biotechnology company listed on US.
This GOSS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.
When the next GOSS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 57.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full GOSS research stays on the stock page; the tape stays on the quote page.
GOSS earnings FAQ
What are GOSS's latest revenue and net income?
Latest cached Gossamer Bio Inc (GOSS) revenue for Dec 31, 2025 was $48.5M. Net income was -$170.4M. Statements: https://lician.com/financials/goss
What is GOSS's latest diluted EPS?
Latest cached Gossamer Bio Inc (GOSS) diluted EPS for Dec 31, 2025 was -$0.75.
What period does the latest GOSS earnings print cover?
The latest cached Gossamer Bio Inc (GOSS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did GOSS revenue change from the prior cached period?
Cached Gossamer Bio Inc (GOSS) revenue was down 57.7% from $114.7M (Dec 31, 2024) to $48.5M (Dec 31, 2025). Statements: https://lician.com/financials/goss
Where are GOSS earnings listed?
Cached earnings facts for Gossamer Bio Inc (GOSS) are listed at https://lician.com/earnings/goss. Statements: https://lician.com/financials/goss
Not investment advice.